Previous 10 | Next 10 |
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
2024-02-07 13:43:49 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...
2024-01-28 11:52:19 ET Summary Baillie Gifford's 13F portfolio value increased from ~$110B to ~$126B this quarter. The top three holdings are MercadoLibre, NVIDIA, and Amazon.com, accounting for ~17% of the portfolio. Baillie Gifford increased stakes in PDD Holdings, Shopify, ...
2024-01-25 04:45:00 ET Summary Patient Capital Management are long-term, contrarian, value investors focusing on growing wealth through Time, not Timing. We operate with the singular purpose of serving clients and helping them enhance their long term investment returns. The strate...
2024-01-24 07:35:00 ET Summary Ensemble Capital Management builds focused investment portfolios to help you preserve your success and enhance your future. Serving clients with assets ranging from about $3 million to $250+ million, Ensemble offers a high level of personalized service t...
2024-01-22 23:30:00 ET Summary During the first three quarters of 2023, Q4 earnings growth expectations remained stable. From an earnings growth contribution perspective, seven sectors have positive earnings contributions while four sectors have negative earnings contributions. ...
2024-01-22 12:27:26 ET More on S&P 500 Index: S&P 500 Sets New Record High As Investors Potentially Shift Focus To Q2 2024 Market Rally Met With Outflows S&P 500: The 'Pump' Is Underway - Watch Out For The 'Dump' Top high-quality growth stocks poi...
2024-01-22 08:30:49 ET Summary Despite recent challenges, Illumina rebounds with strong preliminary Q4 results, led by the successful NovaSeq X launch and strategic alliances, positioning itself as a key player in the genomics transformation. Illumina faces hurdles like the Grail ...
2024-01-19 10:00:10 ET Summary Illumina's stock price has been in decline since its failed attempt to acquire Grail, leading to a 75% decline in share price. Activist investor Carl Icahn has been pushing for changes in Illumina's board and has launched a proxy battle against the c...
2024-01-18 14:41:00 ET Summary The Ensemble Fund seeks to achieve long-term capital appreciation. The Fund invests in a focused portfolio of approximately 15 to 30 securities that meet our demanding criteria. The fourth quarter saw very strong absolute and relative performance in ...
News, Short Squeeze, Breakout and More Instantly...
Illumina to Present Upcoming Strategy Update PR Newswire SAN DIEGO , July 18, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24 , the company will present a Strategy Update on Tuesday, August 13, 2024 starting at ...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 11, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24 , the company will issue results for the second qu...
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / This year may be the most impactful yet in the short history o...